


Brigham Mesothelioma Researchers Investigate Women’s Better Survival Rates
A recent study authored by researchers from the International Mesothelioma Program of the Brigham & Women’s Hospital (IMP) and others has examined the correlation of estrogen and the incidence and survival of mesothelioma. The article describing the study,...
New Mesothelioma Drug Fast Tracked by FDA
The immunotherapy drug ONCOS-102 has been granted Fast Track designation by the Food and Drug Administration (FDA). Fast Track designation speeds up the regulatory review process for the drug. What Is ONCOS-102? ONCOS-102 is an immune activator designed for pleural...
“National Asbestos Awareness Week” established by U.S. Senate
The United States Senate has unanimously passed S.Res 145 establishing “National Asbestos Awareness Week” for the 16th time. April 1, 2021 through April 7, 2021 is now devoted...
EPA Must Fully Protect Americans From Asbestos Exposure and Mesothelioma
In May of 2020, the Environmental Protection Agency (EPA) published a review of continuing dangers associated with asbestos, pursuant to the the amended Toxic Substances Control Act (TSCA). This risk evaluation was widely criticized by scientists and...